| Description |
| Product Type |
Product Size |
| Injection |
6'S |
| Product Company |
| Himont Pharma |
Phloroglucinol 8mg/trimethyl Phloroglucinol 80mg
|
| Product Type |
Product Size |
Product Company |
| Injection |
1'S |
Himmel Pharma |
|
| Product Type |
Product Size |
| Tablet |
600'S |
| Product Company |
| Pfizer |
Mefenamic acid 250mg |
| Product Type |
Product Size |
| Tablet |
30'S |
| Product Company |
| Abbott Pharmaceuticals |
Mebeverine HCL 135mg |
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Himmel Pharma
|
Carboplatin 150mg/15ml |
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Pfizer
|
Cisplatin 50mg
|
| Content | Phloroglucinol is a spasmolytic agent to treat colic, as well as spastic pain of the digestive and biliary tracts.
| Docetaxel is a taxoid antineoplastic agent used in the treatment of various cancers, such as locally advanced or metastatic breast cancer, metastatic prostate cancer, gastric adenocarcinoma, and head and neck cancer. | Mefenamic acid is used for the short-term relief of mild to moderate pain from various conditions such as headache, dental pain, menstrual cramps, and muscle aches.Mefenamic acid is known as a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. | " Mebeverine is an antispasmodic used for the symptomatic treatment of stomach pain and spasms associated with irritable bowel syndrome and other gastrointestinal illnesses." | Carboplatin is an alkylating agent used to treat advanced ovarian cancer.Carboplatin is indicated in combination with an established combination of chemotherapeutic agents for the initial treatment of advanced ovarian carcinoma. Carboplatin is also indicated for the palliative treatment of ovarian carcinoma, recurrent after prior chemotherapy.
| Cisplatin is a platinum based chemotherapy agent used to treat various sarcomas, carcinomas, lymphomas, and germ cell tumors. |
Reviews
There are no reviews yet.